South Korea · Delayed Price · Currency is KRW Genesem Statistics
Total Valuation
Genesem has a market cap or net worth of KRW 89.58 billion. The enterprise value is 91.54 billion.
| Market Cap | 89.58B |
| Enterprise Value | 91.54B |
Important Dates
The last earnings date was Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | Dec 29, 2025 |
Share Statistics
Genesem has 13.15 million shares outstanding.
| Current Share Class | 13.15M |
| Shares Outstanding | 13.15M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 44.53% |
| Owned by Institutions (%) | n/a |
| Float | 7.30M |
Valuation Ratios
The trailing PE ratio is 95.80.
| PE Ratio | 95.80 |
| Forward PE | n/a |
| PS Ratio | 1.58 |
| PB Ratio | 1.78 |
| P/TBV Ratio | 1.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 42.89, with an EV/FCF ratio of -21.05.
| EV / Earnings | 97.90 |
| EV / Sales | 1.61 |
| EV / EBITDA | 42.89 |
| EV / EBIT | 97.18 |
| EV / FCF | -21.05 |
Financial Position
The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.36.
| Current Ratio | 1.50 |
| Quick Ratio | 0.94 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | 8.15 |
| Debt / FCF | -4.16 |
| Interest Coverage | 1.52 |
Financial Efficiency
Return on equity (ROE) is 1.89% and return on invested capital (ROIC) is 1.95%.
| Return on Equity (ROE) | 1.89% |
| Return on Assets (ROA) | 0.75% |
| Return on Invested Capital (ROIC) | 1.95% |
| Return on Capital Employed (ROCE) | 1.84% |
| Weighted Average Cost of Capital (WACC) | 9.51% |
| Revenue Per Employee | 361.51M |
| Profits Per Employee | 5.96M |
| Employee Count | 157 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 2.56 |
Taxes
| Income Tax | -653.51M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +43.67% in the last 52 weeks. The beta is 1.20, so Genesem's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | +43.67% |
| 50-Day Moving Average | 5,926.60 |
| 200-Day Moving Average | 5,460.73 |
| Relative Strength Index (RSI) | 65.54 |
| Average Volume (20 Days) | 142,413 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genesem had revenue of KRW 56.76 billion and earned 935.03 million in profits. Earnings per share was 71.08.
| Revenue | 56.76B |
| Gross Profit | 20.73B |
| Operating Income | 1.03B |
| Pretax Income | 293.75M |
| Net Income | 935.03M |
| EBITDA | 2.22B |
| EBIT | 1.03B |
| Earnings Per Share (EPS) | 71.08 |
Balance Sheet
The company has 16.02 billion in cash and 18.10 billion in debt, with a net cash position of -2.08 billion or -157.90 per share.
| Cash & Cash Equivalents | 16.02B |
| Total Debt | 18.10B |
| Net Cash | -2.08B |
| Net Cash Per Share | -157.90 |
| Equity (Book Value) | 50.21B |
| Book Value Per Share | 3,825.60 |
| Working Capital | 14.75B |
Cash Flow
In the last 12 months, operating cash flow was -2.13 billion and capital expenditures -2.22 billion, giving a free cash flow of -4.35 billion.
| Operating Cash Flow | -2.13B |
| Capital Expenditures | -2.22B |
| Depreciation & Amortization | 1.19B |
| Net Borrowing | -2.53B |
| Free Cash Flow | -4.35B |
| FCF Per Share | -330.57 |
Margins
Gross margin is 36.52%, with operating and profit margins of 1.81% and 1.65%.
| Gross Margin | 36.52% |
| Operating Margin | 1.81% |
| Pretax Margin | 0.52% |
| Profit Margin | 1.65% |
| EBITDA Margin | 3.91% |
| EBIT Margin | 1.81% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.73%.
| Dividend Per Share | 50.00 |
| Dividend Yield | 0.73% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 70.34% |
| Buyback Yield | n/a |
| Shareholder Yield | 0.73% |
| Earnings Yield | 1.04% |
| FCF Yield | -4.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 24, 2025. It was a forward split with a ratio of 1.5.
| Last Split Date | Nov 24, 2025 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
Genesem has an Altman Z-Score of 2.43 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.43 |
| Piotroski F-Score | 4 |